NASDAQ:GLPG
Galapagos NV Stock News
$28.55
-0.220 (-0.765%)
At Close: May 10, 2024
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
12:01pm, Thursday, 21'st May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs on May 20.) * ADC Therapeutics SA (NYSE: ADCT) (went public M
Gilead, Galapagos Announce Positive Data on Inflammatory Drug
09:17am, Thursday, 21'st May 2020
Gilead (GILD) and Galapagos announce positive data on filgotinib for the treatment of ulcerative colitis.
Gilead and Galapagos Score Positive Topline Results For Ulcerative Colitis Trial
06:37am, Thursday, 21'st May 2020
Gilead Sciences (GILD) and Galapagos NV (GLPG) have announced positive topline results from a Phase 2b/3 trial evaluating the efficacy and safety of the selective JAK1 inhibitor filgotinib in 1,348 pa
Gilead and Galapagos Announce Positive Topline Results of Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis
08:03pm, Wednesday, 20'th May 2020
Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced positive topline results from SELECTION, a randomized, double-blind, placebo-controlled, Phase 2b/3 tria
H.C. Wainwright Sticks to Their Buy Rating for Galapagos NV
10:52am, Monday, 11'th May 2020
H.C. Wainwright analyst Debjit Chattopadhyay reiterated a Buy rating on Galapagos (NASDAQ:GLPG) NV on Monday, setting a price target of $302, which is approximately 39.09% above the present share pric
Galapagos NV (GLPG) Q1 2020 Earnings Call Transcript
02:00am, Sunday, 10'th May 2020
At this time, I'd like to turn the conference over to Elizabeth Goodwin. Thank you all for joining us today for the audio webcast of Galapagos' first quarter 2020 results. This recorded webcast is a
Best & Worst ADRs - Monday, April 27
04:04pm, Monday, 27'th Apr 2020
The top-ranked sectors are healthcare, technology, consumer goods, and utilities.
Were Hedge Funds Right About HEICO Corporation (HEI)?
07:40pm, Saturday, 25'th Apr 2020
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
7 stock picks for a volatile market from a manager who ‘finds innovation all over the place’
03:56pm, Saturday, 25'th Apr 2020
The Buffalo Discovery Fund’s Dave Carlsen on seven stock picks, from video-game makers to water-purification companies.
7 Beautiful Biotech Stocks to Buy Here
03:41pm, Friday, 24'th Apr 2020
Covid-19 has put the biotech stocks in the spotlight, but treatments for the pandemic are far from the only reason investors should watch this space.
3 Great Reasons to Buy Gilead Sciences Stock
11:02am, Wednesday, 22'nd Apr 2020
Hint: None of them having anything to do with the biotech's coronavirus drug.
If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now
01:01pm, Sunday, 19'th Apr 2020
Hint: You'll need a couple of commas.
$101.90 Million in Sales Expected for GALAPAGOS NV/S (NASDAQ:GLPG) This Quarter
05:28am, Friday, 17'th Apr 2020
Equities analysts expect GALAPAGOS NV/S (NASDAQ:GLPG) to post $101.90 million in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for GALAPAGOS NV/S’s earning
Analysts Have Conflicting Sentiments on These Healthcare Companies: Danaher (DHR), Theratechnologies (THTX) and Galapagos (GLPG)
05:38pm, Thursday, 16'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Danaher (DHR), Theratechnologies (THTX) and Galapagos (GLPG). Danaher
Galapagos and Ryvu Announce Research Collaboration
06:12am, Thursday, 16'th Apr 2020
Galapagos NV (Euronext: GLPG) (NASDAQ: GLPG) and Ryvu Therapeutics S.A. (WSE: RVU) today announced a collaboration focused on the discovery and development of novel small molecule drugs in inflammatio
